182 related articles for article (PubMed ID: 23670820)
21. [Diagnostic imaging of hemangiomas in the brain].
Toyoda K; Oba H
Brain Nerve; 2011 Jan; 63(1):5-15. PubMed ID: 21228443
[TBL] [Abstract][Full Text] [Related]
22. Inversion-recovery echo-planar MR in adult brain neoplasia.
Sheppard S; Davis PC; Kater G; Peterson JE
AJNR Am J Neuroradiol; 1998 Feb; 19(2):267-73. PubMed ID: 9504476
[TBL] [Abstract][Full Text] [Related]
23. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
24. Metastatic melanoma: correlation of MRI characteristics and histopathology.
Premkumar A; Marincola F; Taubenberger J; Chow C; Venzon D; Schwartzentruber D
J Magn Reson Imaging; 1996; 6(1):190-4. PubMed ID: 8851427
[TBL] [Abstract][Full Text] [Related]
25. Comparison of multi-echo and single-echo gradient-recalled echo sequences for SPIO-enhanced liver MRI at 3 T.
Choi JS; Kim MJ; Kim JH; Choi JY; Chung YE; Park MS; Kim KW
Clin Radiol; 2010 Nov; 65(11):916-23. PubMed ID: 20933647
[TBL] [Abstract][Full Text] [Related]
26. [Contrast-enhanced MR "magnetization transfer technique". Improved tumor contrast, delineation and visibility of intracranial malignant gliomas and metastases in radiosurgical treatment planning].
Hawighorst H; Schreiber W; Debus J; Knopp MV; Engenhart-Cabillic R; Brix G; Essig M; van Kaick G
Strahlenther Onkol; 1997 Dec; 173(12):684-92. PubMed ID: 9454354
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of brain metastases by percentagewise quantification of intratumoral-susceptibility-signals at 3Tesla.
Radbruch A; Graf M; Kramp L; Wiestler B; Floca R; Bäumer P; Roethke M; Stieltjes B; Schlemmer HP; Heiland S; Bendszus M
Eur J Radiol; 2012 Dec; 81(12):4064-8. PubMed ID: 22795527
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
Kang H; Jang S
Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.
Sparacia G; Speciale C; Banco A; Bencivinni F; Midiri M
Neuroradiol J; 2016 Oct; 29(5):326-35. PubMed ID: 27549150
[TBL] [Abstract][Full Text] [Related]
30. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results.
Pinker K; Stavrou I; Szomolanyi P; Hoeftberger R; Weber M; Stadlbauer A; Noebauer-Huhmann IM; Knosp E; Trattnig S
Invest Radiol; 2007 Jun; 42(6):346-51. PubMed ID: 17507804
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
Ding Y; Xing Z; Liu B; Lin X; Cao D
Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
[TBL] [Abstract][Full Text] [Related]
32. MR T1-weighted inversion recovery imaging in detecting brain metastases: could it replace T1-weighted spin-echo imaging?
Qian YF; Yu CL; Zhang C; Yu YQ
AJNR Am J Neuroradiol; 2008 Apr; 29(4):701-4. PubMed ID: 18184839
[TBL] [Abstract][Full Text] [Related]
33. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis.
Ginat DT; Meyers SP
Radiographics; 2012; 32(2):499-516. PubMed ID: 22411945
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility artifact morphology is more conspicuous on susceptibility-weighted imaging compared to T2* gradient echo sequences in the brains of dogs and cats with suspected intracranial disease.
La Rosa C; Donato PD; Specchi S; Bernardini M
Vet Radiol Ultrasound; 2023 May; 64(3):464-472. PubMed ID: 36633010
[TBL] [Abstract][Full Text] [Related]
35. Haemorrhage detection in brain metastases of lung cancer patients using magnetic resonance imaging.
Zhang W; Ma XX; Ji YM; Kang XS; Li CF
J Int Med Res; 2009; 37(4):1139-44. PubMed ID: 19761696
[TBL] [Abstract][Full Text] [Related]
36. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics.
Kim SS; Han MH; Kim JE; Lee CH; Chung HW; Lee JS; Chang KH
Am J Otolaryngol; 2000; 21(6):366-78. PubMed ID: 11115521
[TBL] [Abstract][Full Text] [Related]
38. Signal intensity of brain metastases on T2-weighted images: specificity for metastases from colonic cancers.
Suzuki M; Takashima T; Kadoya M; Ueda T; Arakawa F; Ueda F; Yamashita J; Yamashima T; Nonomura A
Neurochirurgia (Stuttg); 1993 Sep; 36(5):151-5. PubMed ID: 8272166
[TBL] [Abstract][Full Text] [Related]
39. [Cerebral MRI in neurological asymptomatic patients with malignant melanoma].
Schlamann M; Loquai C; Goericke S; Forsting M; Wanke I
Rofo; 2008 Feb; 180(2):143-7. PubMed ID: 18098094
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced MRI coupled with a subtraction technique is useful for treatment response evaluation of malignant melanoma hepatic metastasis.
Lee M; Baek SE; Moon J; Roh YH; Lim JS; Park MS; Kim MJ; Kim H
Oncotarget; 2016 Jun; 7(25):38513-38522. PubMed ID: 27229529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
